{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T17:42:02Z","timestamp":1781804522496,"version":"3.54.5"},"reference-count":130,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.humpath.2026.106032","type":"journal-article","created":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T00:14:31Z","timestamp":1767658471000},"page":"106032","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Select updates in the pathology of kidney, testis, and penile cancer for 2026: Including FLCN-mutated (kidney) tumors, paratesticular mesothelial tumors, and TP53\/HPV status in penile squamous cell carcinoma"],"prefix":"10.1016","volume":"169","author":[{"given":"Burak","family":"Tekin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rumeal D.","family":"Whaley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrina","family":"Collins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lori A.","family":"Erickson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5163-6955","authenticated-orcid":false,"given":"Sounak","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2026.106032_bib1","article-title":"Urinary and Male genital tumours. Lyon","year":"2022","journal-title":"International Agency for Research on Cancer"},{"key":"10.1016\/j.humpath.2026.106032_bib2","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1097\/00000478-200212000-00002","article-title":"Renal tumors in the Birt-Hogg-Dube syndrome","volume":"26","author":"Pavlovich","year":"2002","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2026.106032_bib3","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1038\/bjc.2011.463","article-title":"Renal cancer and pneumothorax risk in Birt-Hogg-Dube syndrome; an analysis of 115 FLCN mutation carriers from 35 BHD families","volume":"105","author":"Houweling","year":"2011","journal-title":"Br J Cancer"},{"key":"10.1016\/j.humpath.2026.106032_bib4","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/s13023-014-0163-z","article-title":"Renal cell tumour characteristics in patients with the birt-hogg-dube cancer susceptibility syndrome: a retrospective, multicentre study","volume":"9","author":"Benusiglio","year":"2014","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.humpath.2026.106032_bib5","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/cas.12601","article-title":"Distinctive expression patterns of glycoprotein non-metastatic B and folliculin in renal tumors in patients with Birt-Hogg-Dube syndrome","volume":"106","author":"Furuya","year":"2015","journal-title":"Cancer Sci"},{"key":"10.1016\/j.humpath.2026.106032_bib6","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.humpath.2019.07.004","article-title":"Incidence of succinate dehydrogenase and fumarate hydratase-deficient renal cell carcinoma based on immunohistochemical screening with SDHA\/SDHB and FH\/2SC","volume":"91","author":"Gupta","year":"2019","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2026.106032_bib7","article-title":"Single-cell analyses of renal cell cancers reveal insights into tumor microenvironment, cell of origin, and therapy response","volume":"118","author":"Zhang","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.humpath.2026.106032_bib8","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/PAS.0000000000002152","article-title":"Hybrid oncocytic tumors (HOTs) in Birt-Hogg-Dube Syndrome Patients-A tale of two cities: sequencing analysis reveals dual lineage markers capturing the 2 cellular populations of HOT","volume":"48","author":"Wang","year":"2024","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2026.106032_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2022.104463","article-title":"Single-cell transcriptomes underscore genetically distinct tumor characteristics and microenvironment for hereditary kidney cancers","volume":"25","author":"Jikuya","year":"2022","journal-title":"iScience"},{"key":"10.1016\/j.humpath.2026.106032_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104596","article-title":"Comparative analyses define differences between BHD-associated renal tumour and sporadic chromophobe renal cell carcinoma","volume":"92","author":"Jikuya","year":"2023","journal-title":"EBioMedicine"},{"key":"10.1016\/j.humpath.2026.106032_bib11","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.urolonc.2021.04.042","article-title":"A contemporary guide to chromosomal copy number profiling in the diagnosis of renal cell carcinoma","volume":"40","author":"Gupta","year":"2022","journal-title":"Urol Oncol"},{"key":"10.1016\/j.humpath.2026.106032_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.humpath.2025.105813","article-title":"Morphologic and immunophenotypic characterization of conventional FLCN-mutated tumors (FMT) compared to a series of 8 non-conventional FMT","volume":"160","author":"Gupta","year":"2025","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2026.106032_bib13","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1038\/modpathol.2017.24","article-title":"TFEB-VEGFA (6p21.1) co-amplified renal cell carcinoma: a distinct entity with potential implications for clinical management","volume":"30","author":"Gupta","year":"2017","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2026.106032_bib14","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.eururo.2025.03.012","article-title":"Renal neoplasia in Birt-Hogg-Dube Syndrome: integrated histopathologic, bulk, and single-cell transcriptomic analysis","volume":"88","author":"Gupta","year":"2025","journal-title":"Eur Urol"},{"key":"10.1016\/j.humpath.2026.106032_bib15","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1097\/PAS.0000000000002435","article-title":"GPNMB expression identifies FLCN -Associated eosinophilic renal tumors with heterogeneous clinicopathologic spectrum and gene expression profiles","volume":"49","author":"Xia","year":"2025","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2026.106032_bib16","article-title":"Conventional FLCN-mutated tumor: a retrospective study of 5 cases with emphasis on diagnostic challenges","volume":"167","author":"Wan","year":"2025","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2026.106032_bib17","article-title":"FLCN-mutated eosinophilic renal tumors: clinicopathologic and molecular analysis of five cases highlighting morphologic heterogeneity","author":"Zhao","year":"2025","journal-title":"Virchows Arch"},{"key":"10.1016\/j.humpath.2026.106032_bib18","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1097\/PAS.0000000000002413","volume":"49","author":"Argani","year":"2025","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2026.106032_bib19","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.ejmg.2016.09.005","article-title":"Bilateral renal tumors in an adult man with Smith-Magenis syndrome: the role of the FLCN gene","volume":"59","author":"Dardour","year":"2016","journal-title":"Eur J Med Genet"},{"key":"10.1016\/j.humpath.2026.106032_bib20","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1002\/ajmg.a.63049","article-title":"A diagnosis of Birt-Hogg-Dube syndrome in individuals with Smith-Magenis syndrome: recommendation for cancer screening","volume":"191","author":"Vocke","year":"2023","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.humpath.2026.106032_bib21","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.eururo.2025.05.003","article-title":"The critical role of FLCN, TFE3, and TFEB in bioenergetic and nutrient sensing, renal cancer tumorigenesis and metabolic health","volume":"88","author":"Linehan","year":"2025","journal-title":"Eur Urol"},{"key":"10.1016\/j.humpath.2026.106032_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0015793","article-title":"Inactivation of the FLCN tumor suppressor gene induces TFE3 transcriptional activity by increasing its nuclear localization","volume":"5","author":"Hong","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.humpath.2026.106032_bib23","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1158\/1541-7786.MCR-18-1235","article-title":"TFE3 Xp11.2 translocation renal cell Carcinoma Mouse model reveals novel therapeutic targets and identifies GPNMB as a diagnostic marker for human disease","volume":"17","author":"Baba","year":"2019","journal-title":"Mol Cancer Res"},{"key":"10.1016\/j.humpath.2026.106032_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.modpat.2024.100426","article-title":"Glycoprotein Nonmetastatic Melanoma Protein B (GPNMB) immunohistochemistry can be a useful ancillary tool to identify perivascular epithelioid cell tumor","volume":"37","author":"Wangsiricharoen","year":"2024","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2026.106032_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.humpath.2025.105768","article-title":"TFE3-rearranged ossifying fibromyxoid tumors are uniquely negative for glycoprotein non-metastatic melanoma protein B: a study of 13 TFE3-rearranged mesenchymal tumors","volume":"157","author":"Tekin","year":"2025","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2026.106032_bib26","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/path.5875","article-title":"GPNMB expression identifies TSC1\/2\/mTOR-associated and MiT family translocation-driven renal neoplasms","volume":"257","author":"Salles","year":"2022","journal-title":"J Pathol"},{"key":"10.1016\/j.humpath.2026.106032_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.humpath.2025.105799","article-title":"Unlocking diagnostic potential: a retrospective analysis of GPNMB immunohistochemistry in nearly 1000 surgical pathology specimens","volume":"159","author":"Li","year":"2025","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2026.106032_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.humpath.2025.105797","article-title":"Evaluation of 3,606 renal cell tumors for TFE3 rearrangements and TFEB alterations via fluorescence in situ hybridization, next generation sequencing, and GPNMB immunohistochemistry","volume":"159","author":"Whaley","year":"2025","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2026.106032_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.humpath.2023.12.006","article-title":"Next generation sequencing-based identification of fusion-driven renal neoplasia: a single institution experience","volume":"152","author":"Tekin","year":"2024","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2026.106032_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.modpat.2025.100873","article-title":"TRIM63 overexpression in FISH-Negative MiTF family altered renal cell carcinoma (MiTF RCC)","volume":"38","author":"Mannan","year":"2025","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2026.106032_bib31","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.humpath.2019.02.008","article-title":"Immunohistochemistry for TFE3 lacks specificity and sensitivity in the diagnosis of TFE3-rearranged neoplasms: a comparative, 2-laboratory study","volume":"87","author":"Sharain","year":"2019","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2026.106032_bib32","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1309\/AJCPDTRTO2Z4UEXD","article-title":"A broad survey of cathepsin K immunoreactivity in human neoplasms","volume":"139","author":"Zheng","year":"2013","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.humpath.2026.106032_bib33","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s00428-024-03855-z","article-title":"Renal epithelioid angiomyolipomas overexpress TFE3 and the TFE3-regulated gene TRIM63 in the absence of TFE3 rearrangement","volume":"485","author":"Collins","year":"2024","journal-title":"Virchows Arch"},{"key":"10.1016\/j.humpath.2026.106032_bib34","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1097\/PAS.0000000000002117","article-title":"Positive GPNMB immunostaining differentiates renal cell carcinoma with fibromyomatous stroma associated with TSC1\/2\/MTOR alterations from others","volume":"47","author":"Li","year":"2023","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2026.106032_bib35","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1097\/PAS.0000000000000248","article-title":"Tuberous sclerosis-associated renal cell carcinoma: a clinicopathologic study of 57 separate carcinomas in 18 patients","volume":"38","author":"Guo","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2026.106032_bib36","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1016\/j.mayocp.2020.11.004","article-title":"Renal neoplasia in tuberous sclerosis: a Study of 41 patients","volume":"96","author":"Gupta","year":"2021","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.humpath.2026.106032_bib37","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.humpath.2022.09.001","article-title":"Lessons from histopathologic examination of nephrectomy specimens in patients with Tuberous sclerosis complex: cysts, angiomyolipomas, and renal cell carcinoma","volume":"129","author":"Gupta","year":"2022","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2026.106032_bib38","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.eururo.2018.06.007","article-title":"Somatic Bi-allelic loss of TSC genes in eosinophilic solid and cystic renal cell carcinoma","volume":"74","author":"Mehra","year":"2018","journal-title":"Eur Urol"},{"key":"10.1016\/j.humpath.2026.106032_bib39","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1097\/PAS.0000000000000838","article-title":"Eosinophilic solid and cystic renal cell carcinoma (ESC RCC): further morphologic and molecular characterization of ESC RCC as a distinct entity","volume":"41","author":"Trpkov","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2026.106032_bib40","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1097\/PAS.0000000000001111","article-title":"Eosinophilic solid and cystic (ESC) renal cell Carcinomas Harbor TSC mutations: molecular analysis supports an expanding clinicopathologic spectrum","volume":"42","author":"Palsgrove","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2026.106032_bib41","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/his.14663","article-title":"Eosinophilic solid and cystic renal cell carcinoma and renal cell carcinomas with TFEB alterations: a comparative study","volume":"81","author":"Lobo","year":"2022","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2026.106032_bib42","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1097\/PAS.0000000000001307","article-title":"TFEB expression profiling in renal cell carcinomas: clinicopathologic correlations","volume":"43","author":"Gupta","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2026.106032_bib43","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.humpath.2022.06.028","article-title":"A diagnostic approach to paratesticular lesions with tubulopapillary architecture: a series of 16 serous borderline tumors\/low-grade serous carcinoma and 14 well-differentiated papillary mesothelial tumors and mesothelioma","volume":"128","author":"Zafar","year":"2022","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2026.106032_bib44","doi-asserted-by":"crossref","first-page":"e167","DOI":"10.1016\/j.mayocp.2016.06.019","article-title":"Paratesticular adenomatoid tumor","volume":"91","author":"Gupta","year":"2016","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.humpath.2026.106032_bib45","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/modpathol.2017.153","article-title":"Adenomatoid tumors of the male and female genital tract are defined by TRAF7 mutations that drive aberrant NF-kB pathway activation","volume":"31","author":"Goode","year":"2018","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2026.106032_bib46","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/his.14669","article-title":"Molecular and immunohistochemical characterisation of mesothelioma of the tunica vaginalis","volume":"81","author":"Anderson","year":"2022","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2026.106032_bib47","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/PAS.0000000000002185","article-title":"Mesothelioma of uncertain malignant potential (MUMP) of the Tunica Vaginalis: proposal for reclassification as \"Complex Mesothelial Tumor of the Tunica Vaginalis\"","volume":"48","author":"Ding","year":"2024","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2026.106032_bib48","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1097\/PAS.0000000000002228","article-title":"Mesothelioma of uncertain malignant potential (MUMP) of the Tunica Vaginalis: proposal for reclassification as \"Complex Mesothelial Tumor of the Tunica Vaginalis\"","volume":"48","author":"Gupta","year":"2024","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2026.106032_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.humpath.2024.04.009","article-title":"Diagnostic pitfalls: florid mesothelial hyperplasia and mesothelioma of the tunica vaginalis","volume":"152","author":"Gupta","year":"2024","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2026.106032_bib50","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/PAS.0b013e31829ab20e","article-title":"Florid mesothelial hyperplasia of the tunica vaginalis mimicking malignant mesothelioma: a clinicopathologic study of 12 cases","volume":"38","author":"Lee","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2026.106032_bib51","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1097\/PAS.0000000000000935","article-title":"PAX8 expression in a subset of malignant peritoneal Mesotheliomas and benign mesothelium has diagnostic implications in the differential diagnosis of ovarian serous carcinoma","volume":"41","author":"Chapel","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2026.106032_bib52","doi-asserted-by":"crossref","first-page":"10285","DOI":"10.1245\/s10434-025-17978-3","article-title":"Clinicopathologic characteristics and clinical outcomes of patients with testicular mesothelioma","volume":"32","author":"Agrawal","year":"2025","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.humpath.2026.106032_bib53","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1038\/s41379-022-01081-z","article-title":"Clinical and molecular validation of BAP1, MTAP, P53, and Merlin immunohistochemistry in diagnosis of pleural mesothelioma","volume":"35","author":"Chapel","year":"2022","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2026.106032_bib54","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/his.15007","article-title":"New developments in mesothelial pathology","volume":"84","author":"Churg","year":"2024","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2026.106032_bib55","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1038\/s41379-020-0646-5","article-title":"EWSR1\/FUS-CREB fusions define a distinctive malignant epithelioid neoplasm with predilection for mesothelial-lined cavities","volume":"33","author":"Argani","year":"2020","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2026.106032_bib56","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1001\/jamaoncol.2017.2918","article-title":"Identification of ALK rearrangements in malignant peritoneal mesothelioma","volume":"4","author":"Hung","year":"2018","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.humpath.2026.106032_bib57","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/s41379-018-0127-2","article-title":"Well-differentiated papillary mesothelioma of the peritoneum is genetically defined by mutually exclusive mutations in TRAF7 and CDC42","volume":"32","author":"Stevers","year":"2019","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2026.106032_bib58","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12061568","article-title":"Well-Differentiated papillary mesothelioma of the peritoneum is genetically distinct from malignant mesothelioma","volume":"12","author":"Shrestha","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.humpath.2026.106032_bib59","doi-asserted-by":"crossref","first-page":"7973","DOI":"10.1245\/s10434-024-16004-2","article-title":"Clinical characteristics and outcomes of patients with well-differentiated papillary peritoneal mesothelial tumors","volume":"31","author":"Offin","year":"2024","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.humpath.2026.106032_bib60","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.pathol.2024.02.016","article-title":"The significance of BAP1 and MTAP\/CDKN2A expression in well-differentiated papillary mesothelial tumour: a series of 21 cases and a review of the literature","volume":"56","author":"Hassan","year":"2024","journal-title":"Pathology"},{"key":"10.1016\/j.humpath.2026.106032_bib61","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.humpath.2018.05.001","article-title":"BAP1 loss is unusual in well-differentiated papillary mesothelioma and may predict development of malignant mesothelioma","volume":"79","author":"Lee","year":"2018","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2026.106032_bib62","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/s41379-019-0347-0","article-title":"Malignant mesothelioma in situ: morphologic features and clinical outcome","volume":"33","author":"Churg","year":"2020","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2026.106032_bib63","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1097\/PAS.0000000000002277","article-title":"Regarding NF2 (Merlin) status in Mesothelioma of uncertain malignant potential (MUMP) or complex mesothelial tumor of the Tunica vaginalis","volume":"48","author":"Ding","year":"2024","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2026.106032_bib64","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/PAP.0b013e3181c66fbc","article-title":"Paratesticular mesothelioma. Report of a case with comprehensive review of literature","volume":"17","author":"Bisceglia","year":"2010","journal-title":"Adv Anat Pathol"},{"key":"10.1016\/j.humpath.2026.106032_bib65","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.urology.2019.01.009","article-title":"Testicular mesothelioma: an analysis of epidemiology, patient outcomes, and prognostic factors","volume":"126","author":"Nazemi","year":"2019","journal-title":"Urology"},{"key":"10.1016\/j.humpath.2026.106032_bib66","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.clgc.2022.09.001","article-title":"Multimodal management of testicular mesothelioma - a retrospective analysis from a tertiary cancer care Centre","volume":"21","author":"Rathinasamy","year":"2023","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.humpath.2026.106032_bib67","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1111\/his.15482","volume":"87","author":"Acosta","year":"2025","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2026.106032_bib68","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1038\/s41379-021-00845-3","article-title":"Comparative molecular analysis of testicular Leydig cell tumors demonstrates distinct subsets of neoplasms with aggressive histopathologic features","volume":"34","author":"Rizzo","year":"2021","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2026.106032_bib69","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1016\/j.mayocp.2025.06.016","article-title":"Malignant testicular sex cord-stromal tumor with signet ring stromal features associated with familial adenomatous polyposis","volume":"100","author":"Tekin","year":"2025","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.humpath.2026.106032_bib70","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1097\/PAS.0000000000002132","article-title":"Germline APC alterations May predispose to testicular sex cord-stromal tumors","volume":"47","author":"Siegmund","year":"2023","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2026.106032_bib71","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/his.15175","article-title":"beta-Catenin alterations in testicular Leydig cell tumour: a immunohistochemical and molecular analysis","volume":"85","author":"Kitagawa","year":"2024","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2026.106032_bib72","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1038\/modpathol.2015.115","article-title":"A survey of DICER1 hotspot mutations in ovarian and testicular sex cord-stromal tumors","volume":"28","author":"Conlon","year":"2015","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2026.106032_bib73","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.ygyno.2017.09.034","article-title":"DICER1-related Sertoli-Leydig cell tumor and gynandroblastoma: clinical and genetic findings from the International Ovarian and Testicular Stromal Tumor Registry","volume":"147","author":"Schultz","year":"2017","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.humpath.2026.106032_bib74","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1097\/PAS.0000000000002022","article-title":"Inflammatory and nested testicular sex cord tumor: a novel neoplasm with aggressive clinical behavior and frequent EWSR1::ATF1 gene fusions","volume":"47","author":"Acosta","year":"2023","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2026.106032_bib75","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1177\/10668969231195043","article-title":"Metastatic testicular sex cord tumor harboring a EWSR1::ATF1 gene Fusion-A case report of a novel neoplasm: \"inflammatory and Nested Testicular Sex Cord Tumor\"","volume":"32","author":"Carrillo-Ng","year":"2024","journal-title":"Int J Surg Pathol"},{"key":"10.1016\/j.humpath.2026.106032_bib76","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1111\/his.14599","article-title":"Large cell calcifying Sertoli cell tumour: a contemporary multi-institutional case series highlighting the diagnostic utility of PRKAR1A immunohistochemistry","volume":"80","author":"Anderson","year":"2022","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2026.106032_bib77","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/j.mayocp.2024.05.031","article-title":"Large-Cell calcifying sertoli cell tumor","volume":"99","author":"Gupta","year":"2024","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.humpath.2026.106032_bib78","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1097\/PAS.0000000000000202","article-title":"PRKAR1A in the development of cardiac myxoma: a study of 110 cases including isolated and syndromic tumors","volume":"38","author":"Maleszewski","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2026.106032_bib79","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1111\/his.15513","article-title":"Loss of expression of STK11\/LKB1 in intratubular large cell hyalinizing Sertoli cell neoplasm","volume":"87","author":"Anderson","year":"2025","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2026.106032_bib80","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.humpath.2022.06.024","article-title":"Somatic-type malignancies in testicular germ cell tumors","volume":"127","author":"Guo","year":"2022","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2026.106032_bib81","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.path.2024.08.010","article-title":"Somatic-type malignancies of germ cell origin: molecular, pathologic, and clinical features","volume":"18","author":"Siegmund","year":"2025","journal-title":"Surg Pathol Clin"},{"key":"10.1016\/j.humpath.2026.106032_bib82","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1097\/PAS.0000000000001703","article-title":"\"Embryonic-type Neuroectodermal Tumor\" Should Replace \"Primitive Neuroectodermal Tumor\" of the Testis and gynecologic tract: a rationale for new nomenclature","volume":"45","author":"Flood","year":"2021","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2026.106032_bib83","doi-asserted-by":"crossref","first-page":"953","DOI":"10.5858\/arpa.2020-0352-OA","article-title":"Immunophenotypic characterization of germ cell tumor-derived primitive neuroectodermal tumors: evidence for frequent neuronal and\/or glial differentiation","volume":"145","author":"Magers","year":"2021","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.humpath.2026.106032_bib84","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s00428-024-03911-8","article-title":"Characterization of testicular embryonic-type neuroectodermal tumor and embryonic-type neuroectodermal tissue admixed with mature neuro-glial tissue using a broad immunohistochemical panel","volume":"487","author":"Di Sciascio","year":"2025","journal-title":"Virchows Arch"},{"key":"10.1016\/j.humpath.2026.106032_bib85","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1097\/PAS.0000000000001206","article-title":"Neuroglial differentiation and neoplasms in testicular germ cell tumors lack immunohistochemical evidence of alterations characteristic of their CNS counterparts: a Study of 13 cases","volume":"43","author":"Matoso","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2026.106032_bib86","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1097\/PAS.0000000000001248","article-title":"Testicular germ cell tumor showing concurrent PNET and neuroglial neoplasms with wide spectrum of grades","volume":"43","author":"Murati","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2026.106032_bib87","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/PAS.0000000000001789","article-title":"Somatic-type malignancies in testicular germ cell tumors: a clinicopathologic Study of 63 cases","volume":"46","author":"Hwang","year":"2022","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2026.106032_bib88","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1016\/S0022-5347(05)66339-2","article-title":"Germ cell tumor associated primitive neuroectodermal tumors","volume":"165","author":"Ganjoo","year":"2001","journal-title":"J Urol"},{"key":"10.1016\/j.humpath.2026.106032_bib89","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1097\/PAS.0000000000002241","article-title":"Primitive embryonic-type Neuroectodermal\/Glandular complexes in testicular germ cell tumors: a mimic of embryonic-type neuroectodermal tumor","volume":"48","author":"Whaley","year":"2024","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2026.106032_bib90","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41572-021-00246-5","volume":"7","author":"Thomas","year":"2021","journal-title":"Penile cancer Nat Rev Dis Primers"},{"key":"10.1016\/j.humpath.2026.106032_bib91","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16112086","article-title":"Therapeutic targets in advanced penile cancer: from bench to bedside","volume":"16","author":"Pagliaro","year":"2024","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.humpath.2026.106032_bib92","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/s41585-025-00994-z","article-title":"Treatment strategies in human papillomavirus-related advanced penile cancer","volume":"22","author":"Longoni","year":"2025","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.humpath.2026.106032_bib93","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.humpath.2023.10.003","article-title":"Assessment of PD-L1, TROP2, and nectin-4 expression in penile squamous cell carcinoma","volume":"142","author":"Tekin","year":"2023","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2026.106032_bib94","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.ajur.2022.02.009","article-title":"The dual pathogenesis of penile neoplasia: the heterogeneous morphology of human papillomavirus-related tumors","volume":"9","author":"Chaux","year":"2022","journal-title":"Asian J Urol"},{"key":"10.1016\/j.humpath.2026.106032_bib95","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.humpath.2024.06.013","article-title":"High-risk human papilloma virus status & outcomes for penile squamous cell carcinoma: a single institution experience","volume":"150","author":"Tekin","year":"2024","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2026.106032_bib96","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S1470-2045(18)30682-X","article-title":"Prevalence of human papillomavirus DNA and p16(INK4a) in penile cancer and penile intraepithelial neoplasia: a systematic review and meta-analysis","volume":"20","author":"Olesen","year":"2019","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.humpath.2026.106032_bib97","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1097\/PAS.0000000000002291","article-title":"p53 Immunohistochemistry Defines a subset of human papillomavirus-independent penile squamous cell carcinomas with adverse prognosis","volume":"48","author":"Trias","year":"2024","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2026.106032_bib98","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1097\/DAD.0000000000002960","article-title":"P16-Negative, high-risk Human Papilloma virus-associated penile squamous cell carcinomas","volume":"47","author":"Tekin","year":"2025","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.humpath.2026.106032_bib99","doi-asserted-by":"crossref","DOI":"10.1016\/j.modpat.2025.100846","article-title":"Human papillomavirus-associated penile squamous cell carcinoma with acquired p16 null immunophenotype","volume":"38","author":"Luu","year":"2025","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2026.106032_bib100","doi-asserted-by":"crossref","DOI":"10.1016\/j.modpat.2023.100250","article-title":"Different mutational landscapes in human papillomavirus-induced and human papillomavirus-independent invasive penile squamous cell cancers","volume":"36","author":"Ermakov","year":"2023","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2026.106032_bib101","doi-asserted-by":"crossref","DOI":"10.1016\/j.modpat.2024.100689","article-title":"Altered TP53, CDKN2A, ATM, EPHA7, POT1, CHEK1, GRIN2A, and EGFR predict shorter survival in penile squamous cell carcinoma","volume":"38","author":"Hojny","year":"2025","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2026.106032_bib102","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1093\/annonc\/mdw216","article-title":"Frequent PD-L1 expression in primary and metastatic penile squamous cell carcinoma: potential opportunities for immunotherapeutic approaches","volume":"27","author":"Udager","year":"2016","journal-title":"Ann Oncol"},{"key":"10.1016\/j.humpath.2026.106032_bib103","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1093\/ajcp\/aqad107","article-title":"Evaluation of programmed cell death ligand 1 expression in a contemporary cohort of penile squamous cell carcinoma and its correlation with clinicopathologic and survival parameters: a study of 134 patients","volume":"161","author":"Lobo","year":"2024","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.humpath.2026.106032_bib104","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.pathol.2023.10.010","article-title":"High tumour mutational burden is associated with strong PD-L1 expression, HPV negativity, and worse survival in penile squamous cell carcinoma: an analysis of 165 cases","volume":"56","author":"Hrudka","year":"2024","journal-title":"Pathology"},{"key":"10.1016\/j.humpath.2026.106032_bib105","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.juro.2016.09.088","article-title":"Expression of programmed death ligand 1 in penile cancer is of prognostic value and associated with HPV status","volume":"197","author":"Ottenhof","year":"2017","journal-title":"J Urol"},{"key":"10.1016\/j.humpath.2026.106032_bib106","article-title":"The prognostic role of HPV or p16INK4a status in penile squamous cell carcinoma: a meta-analysis","volume":"23","author":"Mustasam","year":"2025","journal-title":"J Natl Compr Cancer Netw"},{"key":"10.1016\/j.humpath.2026.106032_bib107","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14246024","article-title":"Prognostic significance of p16 and its relationship with human papillomavirus status in patients with penile squamous cell carcinoma: results of 5 years Follow-Up","volume":"14","author":"Chahoud","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.humpath.2026.106032_bib108","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.humpath.2019.09.013","article-title":"Morphology, p16, HPV, and outcomes in squamous cell carcinoma of the penis: a multi-institutional study","volume":"96","author":"Eich","year":"2020","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2026.106032_bib109","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.mayocp.2024.09.008","article-title":"Human papillomavirus-associated penile squamous cell carcinoma","volume":"100","author":"Tekin","year":"2025","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.humpath.2026.106032_bib110","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.semradonc.2021.02.009","article-title":"Biology of the Radio- and chemo-responsiveness in HPV malignancies","volume":"31","author":"Spiotto","year":"2021","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.humpath.2026.106032_bib111","doi-asserted-by":"crossref","DOI":"10.1016\/j.modpat.2025.100781","article-title":"Evaluation of Nectin-4 and Trop-2: implications for patient outcomes and therapy in penile cancer","volume":"38","author":"Mink","year":"2025","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2026.106032_bib112","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1093\/ajcp\/aqaf022","article-title":"Biomarkers of response to antibody-drug conjugates (TROP2 and nectin-4) and the immune microenvironment (NKG7, PD-L1, and B7-H3) in penile squamous cell carcinoma","volume":"163","author":"Tekin","year":"2025","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.humpath.2026.106032_bib113","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.eururo.2024.03.038","article-title":"Single-cell Atlas of penile cancer reveals TP53 mutations as a driver of an aggressive phenotype, irrespective of human papillomavirus status, and provides clues for treatment personalization","volume":"86","author":"Elst","year":"2024","journal-title":"Eur Urol"},{"key":"10.1016\/j.humpath.2026.106032_bib114","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.eururo.2024.04.032","article-title":"TP53 mutations emerge as a critical biomarker in penile cancer, superseding human papillomavirus status","volume":"86","author":"Chahoud","year":"2024","journal-title":"Eur Urol"},{"key":"10.1016\/j.humpath.2026.106032_bib115","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.pathol.2024.11.006","article-title":"The prognostic value of p53 and Ki-67 expression status in penile cancer: a systematic review and meta-analysis","volume":"57","author":"Sand","year":"2025","journal-title":"Pathology"},{"key":"10.1016\/j.humpath.2026.106032_bib116","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15102719","article-title":"P53 in penile squamous cell carcinoma: a pattern-based immunohistochemical framework with molecular correlation","volume":"15","author":"Trias","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.humpath.2026.106032_bib117","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/3739075","article-title":"The clinical relevance of p16 and p53 status in patients with squamous cell carcinoma of the vulva","volume":"2020","author":"Barlow","year":"2020","journal-title":"J Oncol"},{"key":"10.1016\/j.humpath.2026.106032_bib118","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1038\/s41379-020-0524-1","article-title":"Major p53 immunohistochemical patterns in in situ and invasive squamous cell carcinomas of the vulva and correlation with TP53 mutation status","volume":"33","author":"Tessier-Cloutier","year":"2020","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2026.106032_bib119","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0022-5347(05)64836-7","article-title":"p53 as a new prognostic factor for lymph node metastasis in penile carcinoma: analysis of 82 patients treated with amputation and bilateral lymphadenectomy","volume":"168","author":"Lopes","year":"2002","journal-title":"J Urol"},{"key":"10.1016\/j.humpath.2026.106032_bib120","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/his.14925","article-title":"Human papillomavirus and p53 status define three types of vulvar squamous cell carcinomas with distinct clinical, pathological, and prognostic features","volume":"83","author":"Carreras-Dieguez","year":"2023","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2026.106032_bib121","doi-asserted-by":"crossref","DOI":"10.1016\/j.clgc.2025.102323","article-title":"Impact of TP53 alterations on clinical outcomes in penile squamous cell carcinoma","volume":"23","author":"Li","year":"2025","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.humpath.2026.106032_bib122","series-title":"AJCC Cancer staging manual","author":"Amin","year":"2017"},{"key":"10.1016\/j.humpath.2026.106032_bib123","series-title":"AJCC Cancer staging manual","author":"Edge","year":"2010"},{"key":"10.1016\/j.humpath.2026.106032_bib124","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.humpath.2022.06.010","article-title":"Updates in staging of penile cancer: the evolution, nuances, and issues","volume":"133","author":"Sali","year":"2023","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2026.106032_bib125","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1097\/PAS.0000000000001490","article-title":"A modified histopathologic staging in penile squamous cell carcinoma predicts nodal metastasis and outcome better than the Current AJCC staging","volume":"44","author":"Sali","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2026.106032_bib126","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.humpath.2024.05.008","article-title":"Comparison of a modified staging system with 8th edition AJCC criteria in a North American cohort of pT2\/pT3 HPV-negative penile squamous cell carcinoma","volume":"148","author":"Tekin","year":"2024","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2026.106032_bib127","doi-asserted-by":"crossref","first-page":"e156","DOI":"10.1016\/j.clgc.2018.10.004","article-title":"Pathologic nodal involvement in patients with penile cancer with cavernosal versus spongiosal involvement","volume":"17","author":"Kearns","year":"2019","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.humpath.2026.106032_bib128","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s40880-018-0340-x","article-title":"A modified clinicopathological tumor staging system for survival prediction of patients with penile cancer","volume":"38","author":"Li","year":"2018","journal-title":"Cancer Commun"},{"key":"10.1016\/j.humpath.2026.106032_bib129","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1111\/his.14575","article-title":"A comparative study of AJCC and the modified staging system in pT2\/pT3 penile squamous cell carcinoma - a validation on an external data set","volume":"80","author":"Sali","year":"2022","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2026.106032_bib130","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.humpath.2022.12.012","article-title":"Penile squamous cell carcinoma exclusive to the shaft, with a proposal for a novel staging system","volume":"134","author":"Tekin","year":"2023","journal-title":"Hum Pathol"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817726000018?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817726000018?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T15:35:50Z","timestamp":1772724950000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817726000018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":130,"alternative-id":["S0046817726000018"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2026.106032","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Select updates in the pathology of kidney, testis, and penile cancer for 2026: Including FLCN-mutated (kidney) tumors, paratesticular mesothelial tumors, and TP53\/HPV status in penile squamous cell carcinoma","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2026.106032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106032"}}